These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8772677)

  • 1. Of oocytes and runny noses.
    Rosen MR
    Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
    [No Abstract]   [Full Text] [Related]  

  • 2. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
    Roy M; Dumaine R; Brown AM
    Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
    Suessbrich H; Waldegger S; Lang F; Busch AE
    FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
    Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
    Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of HERG and Kv1.5 by ketoconazole.
    Dumaine R; Roy ML; Brown AM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
    Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Zhou Z; January CT; Genovese A; Marone G; Annunziato L
    Mol Pharmacol; 1998 Jul; 54(1):113-21. PubMed ID: 9658196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-dependent barium block of wild-type and inactivation-deficient HERG channels in Xenopus oocytes.
    Weerapura M; Nattel S; Courtemanche M; Doern D; Ethier N; Hebert T
    J Physiol; 2000 Jul; 526 Pt 2(Pt 2):265-78. PubMed ID: 10896755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the cardiac safety of ebastine. Epilogue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():89-92. PubMed ID: 10597871
    [No Abstract]   [Full Text] [Related]  

  • 10. A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology.
    Roden DM; Balser JR
    Cardiovasc Res; 1999 Nov; 44(2):242-6. PubMed ID: 10690299
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species.
    Taglialatela M; Castaldo P; Iossa S; Pannaccione A; Fresi A; Ficker E; Annunziato L
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11698-703. PubMed ID: 9326673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
    Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Shimizu-Sasamata M; Sato S; Miyata K; Hashimoto K
    Eur J Pharmacol; 2003 Apr; 466(1-2):137-46. PubMed ID: 12679150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drugs, HERG, and the heart.
    Hancox JC; Witchel HJ
    Lancet; 2000 Jul; 356(9227):428. PubMed ID: 10972395
    [No Abstract]   [Full Text] [Related]  

  • 14. Is restoration of intracellular trafficking clinically feasible in the long QT syndrome?: The example of HERG mutations.
    Kaufman ES; Ficker E
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):320-2. PubMed ID: 12716119
    [No Abstract]   [Full Text] [Related]  

  • 15. Long QT syndrome: more questions.
    Moss AJ
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):462. PubMed ID: 11332569
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular diagnosis and treatment of cardiovascular diseases.
    Duff HJ
    Can J Cardiol; 2000 Mar; 16(3):304-6. PubMed ID: 10744791
    [No Abstract]   [Full Text] [Related]  

  • 17. More on the history of arrhythmia in long QT syndrome.
    Csanády M
    J Am Coll Cardiol; 2004 Sep; 44(6):1339; author reply 1339. PubMed ID: 15364343
    [No Abstract]   [Full Text] [Related]  

  • 18. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
    Sanguinetti MC; Jiang C; Curran ME; Keating MT
    Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome.
    Van Langen IM; Birnie E; Alders M; Jongbloed RJ; Le Marec H; Wilde AA
    J Med Genet; 2003 Feb; 40(2):141-5. PubMed ID: 12566525
    [No Abstract]   [Full Text] [Related]  

  • 20. New missense mutation (G626V) in the predicted selectivity filter of the HERG channel associated with familial long QT syndrome.
    Jahr S; Lewalter T; Hesch RD; Lüderitz B; Englisch S
    Hum Mutat; 2000 Jun; 15(6):584. PubMed ID: 10862104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.